{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T11:30:05Z","timestamp":1792063805365,"version":"4.4.0"},"reference-count":151,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","award":["25WS(018)\/2023-24\/EMR-II\/ASPIRE"],"award-info":[{"award-number":["25WS(018)\/2023-24\/EMR-II\/ASPIRE"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024586","name":"Human Resource Development Centre, Council of Scientific And Industrial Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002742","name":"Banaras Hindu University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002742","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","award":["M-14\/84"],"award-info":[{"award-number":["M-14\/84"]}],"id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.micpath.2025.107515","type":"journal-article","created":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T20:20:46Z","timestamp":1743193246000},"page":"107515","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Recent advances in inhibitor development and metabolic targeting in tuberculosis therapy"],"prefix":"10.1016","volume":"203","author":[{"given":"Ritu Raj","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Vidyasagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudhir Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6247-5242","authenticated-orcid":false,"given":"Meenakshi","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.micpath.2025.107515_bib1","doi-asserted-by":"crossref","first-page":"4981","DOI":"10.1038\/s41598-025-89148-0","article-title":"A novel in silico molecular tool for comprehensive differentiation of Mycobacterium species","volume":"15","author":"Diab","year":"2025","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.micpath.2025.107515_bib2","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1128\/JCM.01287-16","article-title":"Mycobacterial taxonomy","volume":"55","author":"Forbes","year":"2017","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.micpath.2025.107515_bib3","series-title":"Structural Biology in Drug Discovery","first-page":"545","article-title":"A comprehensive review on Mycobacterium tuberculosis targets and drug development from a structural perspective","author":"Pedelacq","year":"2020"},{"issue":"1","key":"10.1016\/j.micpath.2025.107515_bib4","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/s41467-023-44252-5","article-title":"BCG vaccination-induced acquired control of mycobacterial growth differs from growth control preexisting to BCG vaccination","volume":"15","author":"van Meijgaarden","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.micpath.2025.107515_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(24)00007-0","article-title":"Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021","author":"Ledesma","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.micpath.2025.107515_bib6","year":"2024","journal-title":"Global TB Report"},{"issue":"1","key":"10.1016\/j.micpath.2025.107515_bib7","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/17460441.2023.2157811","article-title":"Advances in the design of combination therapies for the treatment of tuberculosis","volume":"18","author":"Larkins-Ford","year":"2023","journal-title":"Expet Opin. Drug Discov."},{"issue":"9","key":"10.1016\/j.micpath.2025.107515_bib8","article-title":"Multidrug-resistant tuberculosis and extensively drug-resistant","volume":"5","author":"Seung","year":"2015","journal-title":"Tuberculosis. Cold Spring Harb Perspect Med."},{"issue":"8","key":"10.1016\/j.micpath.2025.107515_bib9","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.3390\/jcm9082541","article-title":"General overview of nontuberculous mycobacteria opportunistic pathogens: Mycobacterium avium and Mycobacterium abscessus","volume":"9","author":"To","year":"2020","journal-title":"JCM"},{"issue":"1","key":"10.1016\/j.micpath.2025.107515_bib10","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1038\/s41467-021-21748-6","article-title":"Biofilm formation in the lung contributes to virulence and drug tolerance of Mycobacterium tuberculosis","volume":"12","author":"Chakraborty","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.micpath.2025.107515_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioflm.2023.100107","article-title":"Mycobacterium biofilms","volume":"5","author":"Mu\u00f1oz-Egea","year":"2023","journal-title":"Biofilm"},{"issue":"5","key":"10.1016\/j.micpath.2025.107515_bib12","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.compbiolchem.2005.07.001","article-title":"Potential drug targets in Mycobacterium tuberculosis through metabolic pathway analysis","volume":"29","author":"Anishetty","year":"2005","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.micpath.2025.107515_bib13","article-title":"Concomitant bedaquiline and delamanid therapy in patients with drug-resistant extra-pulmonary tuberculosis in Mumbai, India","author":"Mongia","year":"2024","journal-title":"SSRN"},{"key":"10.1016\/j.micpath.2025.107515_bib14","first-page":"003377","article-title":"Mycobacterium smegmatis: the vanguard of mycobacterial research","volume":"vol. 205","author":"Sparks","year":"2023"},{"issue":"8","key":"10.1016\/j.micpath.2025.107515_bib15","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1016\/j.apsb.2022.04.014","article-title":"Overcoming Mycobacterium tuberculosis through small molecule inhibitors to break down cell wall synthesis","volume":"12","author":"Kuang","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"issue":"11","key":"10.1016\/j.micpath.2025.107515_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0030466","article-title":"OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice","volume":"3","author":"Matsumoto","year":"2006","journal-title":"PLoS Med."},{"issue":"1","key":"10.1016\/j.micpath.2025.107515_bib17","doi-asserted-by":"crossref","DOI":"10.1128\/ecosalplus.esp-0017-2019","article-title":"Inhibition of RNA polymerase by rifampicin and rifamycin-like molecules","volume":"9","author":"Mosaei","year":"2020","journal-title":"EcoSal Plus"},{"issue":"10","key":"10.1016\/j.micpath.2025.107515_bib18","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1358\/dot.2020.56.10.3161237","article-title":"Pretomanid for the treatment of pulmonary tuberculosis","volume":"56","author":"Thakare","year":"2020","journal-title":"Drugs Today"},{"issue":"3","key":"10.1016\/j.micpath.2025.107515_bib19","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/2049-632X.12143","article-title":"Reversal of Mycobacterium tuberculosis phenotypic drug resistance by 2-aminoimidazole-based small molecules","volume":"70","author":"Ackart","year":"2014","journal-title":"Pathogens Disease"},{"issue":"3","key":"10.1016\/j.micpath.2025.107515_bib20","doi-asserted-by":"crossref","first-page":"215","DOI":"10.7164\/antibiotics.28.215","article-title":"Biological studies on amiclenomycin","volume":"28","author":"Kitahara","year":"1975","journal-title":"J. Antibiot."},{"issue":"6","key":"10.1016\/j.micpath.2025.107515_bib21","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1039\/C9MD00161A","article-title":"Novel antimycobacterial C-21 amide derivatives of the antibiotic fusidic acid: synthesis, pharmacological evaluation and rationalization of media-dependent activity using molecular docking studies in the binding site of human serum albumin","volume":"10","author":"Dziwornu","year":"2019","journal-title":"Med Chem Commun"},{"issue":"1","key":"10.1016\/j.micpath.2025.107515_bib22","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1080\/14756366.2021.1956914","article-title":"Design and characterisation of piperazine-benzofuran integrated dinitrobenzenesulfonamide as Mycobacterium tuberculosis H37Rv strain inhibitors","volume":"36","author":"Murthy","year":"2021","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"7","key":"10.1016\/j.micpath.2025.107515_bib23","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1016\/j.bmc.2010.02.024","article-title":"New 3-methylquinoxaline-2-carboxamide 1,4-di-N-oxide derivatives as anti-Mycobacterium tuberculosis agents","volume":"18","author":"Ancizu","year":"2010","journal-title":"Bioorg. Med. Chem."},{"issue":"4","key":"10.1016\/j.micpath.2025.107515_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0176088","article-title":"Design, synthesis and structure-activity relationship study of wollamide B; a new potential anti TB agent","volume":"12","author":"Asfaw","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2025.107515_bib25","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.3389\/fmicb.2018.02231","article-title":"Optimization and lead selection of benzothiazole amide analogs toward a novel antimycobacterial agent","volume":"9","author":"De Groote","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2025.107515_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.135359","article-title":"Design, synthesis, characterization, and anti-tubercular activity of novel ethyl-3-benzoyl-6, 8-difluoroindolizine-1-carboxylate analogues: molecular target identification and molecular docking studies","volume":"1284","author":"Mundhe","year":"2023","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.micpath.2025.107515_bib27","article-title":"Design, synthesis, molecular docking and biological activity of pyrazolo[3,4- b ]pyridines as promising lead candidates against","author":"Rao","year":"2023","journal-title":"Mycobacterium Tuberculosis. Bioinformatics"},{"key":"10.1016\/j.micpath.2025.107515_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106904","article-title":"Synthesis, characterization, in vitro antimycobacterial and cytotoxicity evaluation, DFT calculations, molecular docking and ADME studies of new isomeric benzimidazole-1,2,3-triazole-quinoline hybrid mixtures","volume":"141","author":"Nyoni","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.micpath.2025.107515_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.136540","article-title":"Design, synthesis, single-crystal X-ray and docking studies of imidazopyridine analogues as potent anti-TB agents","volume":"1295","author":"K","year":"2024","journal-title":"J. Mol. Struct."},{"issue":"23","key":"10.1016\/j.micpath.2025.107515_bib30","doi-asserted-by":"crossref","first-page":"20262","DOI":"10.1021\/acsomega.2c07267","article-title":"Synthesis, characterization, antitubercular activity, and molecular docking studies of pyrazolylpyrazoline-clubbed triazole and tetrazole hybrids","volume":"8","author":"Zala","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.micpath.2025.107515_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115633","article-title":"Synthesis, biological evaluation and docking studies of silicon incorporated diarylpyrroles as MmpL3 inhibitors: an effective strategy towards development of potent anti-tubercular agents","volume":"259","author":"Vasudevan","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.micpath.2025.107515_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.135556","article-title":"Green synthesis, antimycobacterial evaluation and molecular docking studies of novel 2,3-dihydro-1H-pyrazol-4-ylnaphthalene-1,4-diones","volume":"1286","author":"Hiwarale","year":"2023","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.micpath.2025.107515_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.rechem.2022.100726","article-title":"Synthesis, molecular structure investigation, biological evaluation and docking studies of novel spirothiazolidinones","volume":"5","author":"Pandey","year":"2023","journal-title":"Results in Chemistry"},{"issue":"1","key":"10.1016\/j.micpath.2025.107515_bib34","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2023.2229070","article-title":"Synthesis, antimycobacterial evaluation, and molecular docking study of 1,2,4-triazole derivatives","volume":"38","author":"Xia","year":"2023","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.micpath.2025.107515_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106591","article-title":"Isatin-pyrimidine hybrid derivatives as enoyl acyl carrier protein reductase (InhA) inhibitors against Mycobacterium tuberculosis","volume":"138","author":"Khalifa","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.micpath.2025.107515_bib36","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.fitote.2017.08.009","article-title":"New amide and dioxopiperazine derivatives from leaves of Breynia nivosa","volume":"122","author":"Umeokoli","year":"2017","journal-title":"Fitoterapia"},{"issue":"1","key":"10.1016\/j.micpath.2025.107515_bib37","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13065-017-0271-7","article-title":"Synthesis, docking study and biological evaluation of some new thiourea derivatives bearing benzenesulfonamide moiety","volume":"11","author":"Ghorab","year":"2017","journal-title":"Chem. Cent. J."},{"issue":"14","key":"10.1016\/j.micpath.2025.107515_bib38","doi-asserted-by":"crossref","first-page":"9731","DOI":"10.1021\/acsomega.1c00369","article-title":"Synthesis and biological evaluation of novel benzhydrylpiperazine-coupled nitrobenzenesulfonamide hybrids","volume":"6","author":"Murthy","year":"2021","journal-title":"ACS Omega"},{"key":"10.1016\/j.micpath.2025.107515_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2023.121449","article-title":"Antimicrobial peptides grafted onto the surface of N-acetylcysteine-chitosan nanoparticles can revitalize drugs against clinical isolates of Mycobacterium tuberculosis","volume":"323","author":"Primo","year":"2024","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.micpath.2025.107515_bib40","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.phrs.2017.10.011","article-title":"Antimicrobial peptides as an alternative to anti-tuberculosis drugs","volume":"128","author":"AlMatar","year":"2018","journal-title":"Pharmacol. Res."},{"issue":"8","key":"10.1016\/j.micpath.2025.107515_bib41","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1086\/424463","article-title":"Role of human neutrophil peptide\u20131 as a possible adjunct to antituberculosis chemotherapy","volume":"190","author":"Kalita","year":"2004","journal-title":"J. Infect. Dis."},{"issue":"12","key":"10.1016\/j.micpath.2025.107515_bib42","doi-asserted-by":"crossref","first-page":"10957","DOI":"10.1007\/s11033-012-1997-x","article-title":"Cathelicidins: family of antimicrobial peptides. A review","volume":"39","author":"Ko\u015bciuczuk","year":"2012","journal-title":"Mol. Biol. Rep."},{"issue":"5","key":"10.1016\/j.micpath.2025.107515_bib43","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/jac\/47.5.575","article-title":"In vitro activity of PR-39, a proline-arginine-rich peptide, against susceptible and multi-drug-resistant Mycobacterium tuberculosis","volume":"47","author":"Linde","year":"2001","journal-title":"J. Antimicrob. Chemother."},{"issue":"2","key":"10.1016\/j.micpath.2025.107515_bib44","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1021\/cr030105v","article-title":"van der Donk WA. Biosynthesis and Mode of Action of Lantibiotics","volume":"105","author":"Chatterjee","year":"2005","journal-title":"Chem Rev"},{"issue":"1","key":"10.1016\/j.micpath.2025.107515_bib45","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1574-6968.1998.tb12896.x","article-title":"Mechanism of antimicrobial action of indolicidin","volume":"160","author":"Subbalakshmi","year":"1998","journal-title":"FEMS (Fed. Eur. Microbiol. Soc.) Microbiol. Lett."},{"key":"10.1016\/j.micpath.2025.107515_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2021.151855","article-title":"Antibacterial peptide RP557 increases the antibiotic sensitivity of Mycobacterium abscessus by inhibiting biofilm formation","volume":"807","author":"Li","year":"2022","journal-title":"Sci. Total Environ."},{"issue":"37","key":"10.1016\/j.micpath.2025.107515_bib47","doi-asserted-by":"crossref","first-page":"10996","DOI":"10.1021\/acs.langmuir.0c01790","article-title":"Low fouling peptides with an all (d) amino acid sequence provide enhanced stability against proteolytic degradation while maintaining low antifouling properties","volume":"36","author":"Beyer","year":"2020","journal-title":"Langmuir"},{"issue":"4819","key":"10.1016\/j.micpath.2025.107515_bib48","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/193987a0","article-title":"Fusidic acid: a new antibiotic","volume":"193","author":"Godtfredsen","year":"1962","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.micpath.2025.107515_bib49","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/adc.2003.019695","article-title":"Fusidic acid resistance in Staphylococcus aureus","volume":"89","author":"Dobie","year":"2004","journal-title":"Arch. Dis. Child."},{"issue":"3","key":"10.1016\/j.micpath.2025.107515_bib50","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/jac\/26.3.381","article-title":"Comparative in-vitro activities of ten fluoroquinolones and fusidic acid against Mycobacterium spp","volume":"26","author":"Van Caekenberghe","year":"1990","journal-title":"J. Antimicrob. Chemother."},{"issue":"1","key":"10.1016\/j.micpath.2025.107515_bib51","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3390\/pr12010111","article-title":"Combined application of juniperus communis essential oil and amikacin, clarithromycin and rifampicin against Mycobacterium avium and Mycobacterium intracellulare","volume":"12","author":"Peru\u010d","year":"2024","journal-title":"Processes"},{"issue":"3","key":"10.1016\/j.micpath.2025.107515_bib52","first-page":"223","article-title":"Juniper and immortelle essential oils synergistically inhibit adhesion of nontuberculous mycobacteria to Acanthamoeba castellanii","volume":"71","author":"Peru\u010d","year":"2020","journal-title":"Arh. Hig. Rada. Toksikol."},{"issue":"11","key":"10.1016\/j.micpath.2025.107515_bib53","doi-asserted-by":"crossref","first-page":"e01213","DOI":"10.1128\/AAC.01213-19","article-title":"Adaptation of Mycobacterium tuberculosis to biofilm growth is genetically linked to drug tolerance","volume":"63","author":"Richards","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.micpath.2025.107515_bib54","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/s12906-017-1801-5","article-title":"Inhibition of biofilm formation in Mycobacterium smegmatis by Parinari curatellifolia leaf extracts","volume":"17","author":"Bhunu","year":"2017","journal-title":"BMC Complement Altern Med"},{"key":"10.1016\/j.micpath.2025.107515_bib55","series-title":"Detection of Mycobacterium Smegmatis Biofilm and its Control by Natural Agents","author":"Abidi","year":"2014"},{"issue":"3","key":"10.1016\/j.micpath.2025.107515_bib56","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3390\/pathogens6030042","article-title":"Inhibition of adherence of Mycobacterium avium to plumbing surface biofilms of Methylobacterium spp","volume":"6","author":"Mu\u00f1oz Egea","year":"2017","journal-title":"Pathogens"},{"issue":"1","key":"10.1016\/j.micpath.2025.107515_bib57","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41429-019-0232-6","article-title":"Inhibition of Mycobacterium abscessus, M. chelonae, and M. fortuitum biofilms by Methylobacterium sp","volume":"73","author":"Garc\u00eda-Coca","year":"2020","journal-title":"J. Antibiot."},{"key":"10.1016\/j.micpath.2025.107515_bib58","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.2147\/IDR.S218638","article-title":"Phage therapy as a renewed therapeutic approach to mycobacterial infections: a comprehensive review","volume":"12","author":"Azimi","year":"2019","journal-title":"IDR"},{"issue":"8","key":"10.1016\/j.micpath.2025.107515_bib59","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1086\/343812","article-title":"Killing of Mycobacterium avium and Mycobacterium tuberculosis by a mycobacteriophage delivered by a nonvirulent Mycobacterium: a model for phage therapy of intracellular bacterial pathogens","volume":"186","author":"Broxmeyer","year":"2002","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.micpath.2025.107515_bib60","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/s42003-024-06006-x","article-title":"Bacteriophage therapy for the treatment of Mycobacterium tuberculosis infections in humanized mice","volume":"7","author":"Yang","year":"2024","journal-title":"Commun. Biol."},{"issue":"1","key":"10.1016\/j.micpath.2025.107515_bib61","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/nrd2201","article-title":"Drugs for bad bugs: confronting the challenges of antibacterial discovery","volume":"6","author":"Payne","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"issue":"23","key":"10.1016\/j.micpath.2025.107515_bib62","doi-asserted-by":"crossref","first-page":"17326","DOI":"10.1021\/acs.jmedchem.1c01407","article-title":"Synthetic sansanmycin analogues as potent Mycobacterium tuberculosis translocase I inhibitors","volume":"64","author":"Tran","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.micpath.2025.107515_bib63","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ebiom.2016.05.006","article-title":"Antitubercular drugs for an old target: GSK693 as a promising InhA direct inhibitor","volume":"8","author":"Mart\u00ednez-Hoyos","year":"2016","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.micpath.2025.107515_bib64","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12581","article-title":"Identification of KasA as the cellular target of an anti-tubercular scaffold","volume":"7","author":"Abrahams","year":"2016","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.micpath.2025.107515_bib65","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.3390\/biomedicines10112793","article-title":"MmpL3 inhibition as a promising approach to develop novel therapies against tuberculosis: a spotlight on SQ109, clinical studies, and patents literature","volume":"10","author":"Imran","year":"2022","journal-title":"Biomedicines"},{"issue":"6","key":"10.1016\/j.micpath.2025.107515_bib66","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1080\/14728222.2017.1327577","article-title":"Type-II NADH Dehydrogenase (NDH-2): a promising therapeutic target for antitubercular and antibacterial drug discovery","volume":"21","author":"Sellamuthu","year":"2017","journal-title":"Expert Opin. Ther. Targets"},{"issue":"17","key":"10.1016\/j.micpath.2025.107515_bib67","doi-asserted-by":"crossref","first-page":"11456","DOI":"10.1074\/jbc.M508844200","article-title":"Steady-state kinetics and inhibitory action of antitubercular phenothiazines on Mycobacterium tuberculosis type-II NADH-menaquinone oxidoreductase (NDH-2)","volume":"281","author":"Yano","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"5707","key":"10.1016\/j.micpath.2025.107515_bib68","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1126\/science.1106753","article-title":"A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis","volume":"307","author":"Andries","year":"2005","journal-title":"Science."},{"issue":"4","key":"10.1016\/j.micpath.2025.107515_bib69","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1021\/acs.jmedchem.6b01358","article-title":"Discovery of imidazo[1,2- a ]pyridine ethers and squaramides as selective and potent inhibitors of mycobacterial adenosine triphosphate (ATP) synthesis","volume":"60","author":"Tantry","year":"2017","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.micpath.2025.107515_bib70","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1128\/AAC.01601-09","article-title":"In vitro interactions between new antitubercular drug candidates SQ109 and TMC207","volume":"54","author":"Reddy","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"issue":"12","key":"10.1016\/j.micpath.2025.107515_bib71","doi-asserted-by":"crossref","first-page":"5293","DOI":"10.1021\/jm5003606","article-title":"Lead optimization of a novel series of imidazo[1,2- a ]pyridine amides leading to a clinical candidate (Q203) as a multi- and extensively-drug-resistant anti-tuberculosis agent","volume":"57","author":"Kang","year":"2014","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.micpath.2025.107515_bib72","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1002\/med.21779","article-title":"QcrB in Mycobacterium tuberculosis : the new drug target of antitubercular agents","volume":"41","author":"Bahuguna","year":"2021","journal-title":"Med. Res. Rev."},{"issue":"6","key":"10.1016\/j.micpath.2025.107515_bib73","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02439-17","article-title":"Imidazopyridine compounds inhibit mycobacterial growth by depleting ATP levels","volume":"62","author":"O'Malley","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"issue":"5","key":"10.1016\/j.micpath.2025.107515_bib74","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.tube.2012.06.001","article-title":"Salicylanilide derivatives block Mycobacterium tuberculosis through inhibition of isocitrate lyase and methionine aminopeptidase","volume":"92","author":"Kr\u00e1tk\u00fd","year":"2012","journal-title":"Tuberculosis"},{"key":"10.1016\/j.micpath.2025.107515_bib75","series-title":"Cell Biology by the Numbers","author":"Milo","year":"2015"},{"issue":"5","key":"10.1016\/j.micpath.2025.107515_bib76","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.3390\/molecules25051205","article-title":"Targeting genome integrity in Mycobacterium tuberculosis: from nucleotide synthesis to DNA replication and repair","volume":"25","author":"Miggiano","year":"2020","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.micpath.2025.107515_bib77","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1128\/microbiolspec.TBTB2-0027-2016","article-title":"DNA replication in Mycobacterium tuberculosis. Jacobs jr. WR","volume":"5","author":"Ditse","year":"2017","journal-title":"Microbiol. Spectr."},{"issue":"3","key":"10.1016\/j.micpath.2025.107515_bib78","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033886","article-title":"Identification of novel Mt-Guab2 inhibitor series active against M. tuberculosis","volume":"7","author":"Usha","year":"2012","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.micpath.2025.107515_bib79","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/j.bmcl.2018.04.045","article-title":"Hit discovery of Mycobacterium tuberculosis inosine 5\u2032-monophosphate dehydrogenase, GuaB2, inhibitors","volume":"28","author":"Sahu","year":"2018","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"1","key":"10.1016\/j.micpath.2025.107515_bib80","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1021\/acsinfecdis.6b00102","article-title":"The inosine monophosphate dehydrogenase, GuaB2, is a vulnerable new bactericidal drug target for tuberculosis","volume":"3","author":"Singh","year":"2017","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.micpath.2025.107515_bib81","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/B978-0-444-59565-2.00052-6","article-title":"Metabolic disorders of purine metabolism affecting the nervous system","volume":"113","author":"Jinnah","year":"2013","journal-title":"Handb. Clin. Neurol."},{"issue":"1","key":"10.1016\/j.micpath.2025.107515_bib82","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/s41598-017-01057-z","article-title":"Structural investigations on orotate phosphoribosyltransferase from Mycobacterium tuberculosis, a key enzyme of the de novo pyrimidine biosynthesis","volume":"7","author":"Donini","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micpath.2025.107515_bib83","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ejmech.2012.04.031","article-title":"Pyrimidin-2(1H)-ones based inhibitors of Mycobacterium tuberculosis orotate phosphoribosyltransferase","volume":"54","author":"Breda","year":"2012","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.micpath.2025.107515_bib84","doi-asserted-by":"crossref","DOI":"10.1038\/srep27792","article-title":"Predictive modeling targets thymidylate synthase ThyX in Mycobacterium tuberculosis","volume":"6","author":"Djaout","year":"2016","journal-title":"Sci. Rep."},{"issue":"17","key":"10.1016\/j.micpath.2025.107515_bib85","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202300279","article-title":"Inhibitors of aspartate transcarbamoylase inhibit Mycobacterium tuberculosis growth","volume":"18","author":"Du","year":"2023","journal-title":"ChemMedChem"},{"issue":"27","key":"10.1016\/j.micpath.2025.107515_bib86","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.2174\/1381612819666131118203641","article-title":"New approaches to target the mycolic acid biosynthesis pathway for the development of tuberculosis therapeutics","volume":"20","author":"North","year":"2014","journal-title":"Curr. Pharm. Des."},{"issue":"2","key":"10.1016\/j.micpath.2025.107515_bib87","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1017\/S0031182016002377","article-title":"Mycobacterial cell wall biosynthesis: a multifaceted antibiotic target","volume":"145","author":"Abrahams","year":"2018","journal-title":"Parasitology"},{"key":"10.1016\/j.micpath.2025.107515_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112408","article-title":"Development of small-molecule inhibitors of fatty acyl-AMP and fatty acyl-CoA ligases in Mycobacterium tuberculosis","volume":"201","author":"Baran","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.micpath.2025.107515_bib89","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0163-7827(02)00007-3","article-title":"Multi-subunit acetyl-CoA carboxylases","volume":"41","author":"Cronan","year":"2002","journal-title":"Prog. Lipid Res."},{"issue":"30","key":"10.1016\/j.micpath.2025.107515_bib90","doi-asserted-by":"crossref","first-page":"27967","DOI":"10.1074\/jbc.M103687200","article-title":"Biochemical characterization of acyl carrier protein (AcpM) and malonyl-CoA:AcpM transacylase (mtFabD), two major components ofMycobacterium tuberculosis fatty acid synthase II","volume":"276","author":"Kremer","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"36","key":"10.1016\/j.micpath.2025.107515_bib91","doi-asserted-by":"crossref","first-page":"28201","DOI":"10.1074\/jbc.M003241200","article-title":"Identification and substrate specificity of \u03b2-ketoacyl (acyl carrier protein) synthase III (mtFabH) from Mycobacterium tuberculosis","volume":"275","author":"Choi","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.micpath.2025.107515_bib92","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1099\/00221287-148-4-951","article-title":"MabA (FabG1), a Mycobacterium tuberculosis protein involved in the long-chain fatty acid elongation system FAS-II","volume":"148","author":"Marrakchi","year":"2002","journal-title":"Microbiology"},{"key":"10.1016\/j.micpath.2025.107515_bib93","first-page":"2","article-title":"The molecular genetics of mycolic acid biosynthesis","volume":"vol. 2","author":"Pawe\u0141czyk","year":"2014"},{"issue":"6981","key":"10.1016\/j.micpath.2025.107515_bib94","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/nature02384","article-title":"Enzymic activation and transfer of fatty acids as acyl-adenylates in mycobacteria","volume":"428","author":"Trivedi","year":"2004","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.micpath.2025.107515_bib95","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1128\/CMR.18.1.81-101.2005","article-title":"Pathway to synthesis and processing of mycolic acids in Mycobacterium tuberculosis","volume":"18","author":"Takayama","year":"2005","journal-title":"Clin. Microbiol. Rev."},{"issue":"S1","key":"10.1016\/j.micpath.2025.107515_bib96","doi-asserted-by":"crossref","DOI":"10.1096\/fasebj.22.1_supplement.839.4","article-title":"Structure\u2010based inhibitor design of AccD5\/AccD6, essential carboxyltransferases of Mycobacterium tuberculosis","volume":"22","author":"Lin","year":"2008","journal-title":"FASEB j."},{"issue":"10","key":"10.1016\/j.micpath.2025.107515_bib97","doi-asserted-by":"crossref","first-page":"6122","DOI":"10.1128\/AAC.02574-13","article-title":"Structure, activity, and inhibition of the carboxyltransferase \u03b2-subunit of acetyl coenzyme A carboxylase (AccD6) from Mycobacterium tuberculosis","volume":"58","author":"Reddy","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"issue":"7","key":"10.1016\/j.micpath.2025.107515_bib98","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006306","article-title":"Platensimycin activity against mycobacterial \u03b2-ketoacyl-ACP synthases","volume":"4","author":"Brown","year":"2009","journal-title":"PLoS One"},{"issue":"22","key":"10.1016\/j.micpath.2025.107515_bib99","doi-asserted-by":"crossref","first-page":"16857","DOI":"10.1074\/jbc.M000569200","article-title":"Thiolactomycin and related analogues as novel anti-mycobacterial agents targeting KasA and KasB condensing enzymes inMycobacterium tuberculosis","volume":"275","author":"Kremer","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"24","key":"10.1016\/j.micpath.2025.107515_bib100","doi-asserted-by":"crossref","first-page":"6402","DOI":"10.1016\/j.bmcl.2008.10.097","article-title":"Synthesis and biological evaluation of novel sulfonyl-naphthalene-1,4-diols as FabH inhibitors","volume":"18","author":"Alhamadsheh","year":"2008","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"2","key":"10.1016\/j.micpath.2025.107515_bib101","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/jac\/43.2.219","article-title":"Antimycobacterial activity of cerulenin and its effects on lipid biosynthesis","volume":"43","author":"Parrish","year":"1999","journal-title":"J. Antimicrob. Chemother."},{"issue":"2","key":"10.1016\/j.micpath.2025.107515_bib102","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1021\/id500032q","article-title":"Covalent modification of the Mycobacterium tuberculosis FAS-II dehydratase by Isoxyl and thiacetazone","volume":"1","author":"Grzegorzewicz","year":"2015","journal-title":"ACS Infect. Dis."},{"issue":"1","key":"10.1016\/j.micpath.2025.107515_bib103","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40203-015-0014-1","article-title":"Molecular docking studies on InhA, MabA and PanK enzymes from Mycobacterium tuberculosis of ellagic acid derivatives from Ludwigia adscendens and Trewia nudiflora","volume":"3","author":"Shilpi","year":"2015","journal-title":"Silico Pharmacol"},{"issue":"5144","key":"10.1016\/j.micpath.2025.107515_bib104","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1126\/science.8284673","article-title":"inhA , a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis","volume":"263","author":"Banerjee","year":"1994","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.micpath.2025.107515_bib105","first-page":"241","article-title":"Triclosan derivatives: towards potent inhibitors of drug-sensitive and drug-resistant","volume":"4","author":"Freundlich","year":"2009","journal-title":"Mycobacterium tuberculosis. ChemMedChem."},{"issue":"28","key":"10.1016\/j.micpath.2025.107515_bib106","doi-asserted-by":"crossref","first-page":"11565","DOI":"10.1073\/pnas.1302114110","article-title":"Diarylcoumarins inhibit mycolic acid biosynthesis and kill Mycobacterium tuberculosis by targeting FadD32","volume":"110","author":"Stanley","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.micpath.2025.107515_bib107","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1080\/07391102.2018.1462734","article-title":"Molecular dynamics simulation and binding free energy studies of novel leads belonging to the benzofuran class inhibitors of Mycobacterium tuberculosis Polyketide Synthase 13","volume":"37","author":"Cruz","year":"2019","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.micpath.2025.107515_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112772","article-title":"Synthesis and evaluation of thiophene based small molecules as potent inhibitors of Mycobacterium tuberculosis","volume":"208","author":"Meena","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.micpath.2025.107515_bib109","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0056980","article-title":"Improved BM212 MmpL3 inhibitor analogue shows efficacy in acute murine model of tuberculosis infection","volume":"8","author":"Poce","year":"2013","journal-title":"PLoS One"},{"issue":"214","key":"10.1016\/j.micpath.2025.107515_bib110","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007355","article-title":"Indolcarboxamide is a preclinical candidate for treating multidrug-resistant tuberculosis","volume":"5","author":"Rao","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.micpath.2025.107515_bib111","doi-asserted-by":"crossref","DOI":"10.2139\/ssrn.4282964","article-title":"Discovery and biological evaluation of an adamantyl-amide derivative with likely MmpL3 inhibitory activity","author":"Kapp","year":"2022","journal-title":"SSRN Journal"},{"issue":"4","key":"10.1016\/j.micpath.2025.107515_bib112","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060933","article-title":"Tetrahydropyrazolo[1,5-a]Pyrimidine-3-Carboxamide and N-Benzyl-6\u2032,7\u2032-Dihydrospiro[Piperidine-4,4\u2032-Thieno[3,2-c]Pyran] analogues with bactericidal efficacy against Mycobacterium tuberculosis targeting MmpL3","volume":"8","author":"Remui\u00f1\u00e1n","year":"2013","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.micpath.2025.107515_bib113","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1021\/cb300151m","article-title":"Identification of novel inhibitors of M. tuberculosis growth using whole cell based high-throughput screening","volume":"7","author":"Stanley","year":"2012","journal-title":"ACS Chem. Biol."},{"issue":"4","key":"10.1016\/j.micpath.2025.107515_bib114","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1128\/AAC.05742-11","article-title":"Antigen 85C inhibition restricts Mycobacterium tuberculosis growth through disruption of cord factor biosynthesis","volume":"56","author":"Warrier","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"issue":"10","key":"10.1016\/j.micpath.2025.107515_bib115","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/j.jmb.2013.02.019","article-title":"Crystal structures identify an atypical two-metal-ion mechanism for uridyltransfer in GlmU: its significance to sugar nucleotidyl transferases","volume":"425","author":"Jagtap","year":"2013","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.micpath.2025.107515_bib116","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113568","article-title":"The Mur enzymes chink in the armour of Mycobacterium tuberculosis cell wall","volume":"222","author":"Shinde","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.micpath.2025.107515_bib117","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1074\/jbc.M411006200","article-title":"Identification of the namH gene, encoding the hydroxylase responsible for the N-glycolylation of the mycobacterial peptidoglycan","volume":"280","author":"Raymond","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.micpath.2025.107515_bib118","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.tetlet.2006.11.160","article-title":"Chemoenzymatic synthesis of Park's nucleotide: toward the development of high-throughput screening for MraY inhibitors","volume":"48","author":"Kurosu","year":"2007","journal-title":"Tetrahedron Lett."},{"issue":"2","key":"10.1016\/j.micpath.2025.107515_bib119","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1574-6968.2011.02446.x","article-title":"An assay for exogenous sources of purified MurG, enabled by the complementation of Escherichia coli murG(Ts) by the Mycobacterium tuberculosis homologue","volume":"326","author":"Jha","year":"2012","journal-title":"FEMS Microbiol. Lett."},{"issue":"6193","key":"10.1016\/j.micpath.2025.107515_bib120","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1126\/science.1254522","article-title":"MurJ is the flippase of lipid-linked precursors for peptidoglycan biogenesis","volume":"345","author":"Sham","year":"2014","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.micpath.2025.107515_bib121","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1038\/emboj.2011.61","article-title":"Identification of FtsW as a transporter of lipid-linked cell wall precursors across the membrane: FtsW transports Lipid II across the membrane","volume":"30","author":"Mohammadi","year":"2011","journal-title":"EMBO J."},{"issue":"2","key":"10.1016\/j.micpath.2025.107515_bib122","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1574-6976.2008.00105.x","article-title":"The penicillin-binding proteins: structure and role in peptidoglycan biosynthesis","volume":"32","author":"Sauvage","year":"2008","journal-title":"FEMS Microbiol. Rev."},{"issue":"23","key":"10.1016\/j.micpath.2025.107515_bib123","doi-asserted-by":"crossref","first-page":"14392","DOI":"10.1074\/jbc.273.23.14392","article-title":"The eukaryotic UDP-N-acetylglucosamine pyrophosphorylases","volume":"273","author":"Mio","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"13","key":"10.1016\/j.micpath.2025.107515_bib124","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/j.carres.2011.05.024","article-title":"Design and synthesis of novel cell wall inhibitors of Mycobacterium tuberculosis GlmM and GlmU","volume":"346","author":"Li","year":"2011","journal-title":"Carbohydr. Res."},{"issue":"17","key":"10.1016\/j.micpath.2025.107515_bib125","doi-asserted-by":"crossref","first-page":"4997","DOI":"10.1080\/07391102.2019.1696231","article-title":"Identification of peptidomimetic compounds as potential inhibitors against MurA enzyme of Mycobacterium tuberculosis","volume":"38","author":"Kumar","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"1","key":"10.1016\/j.micpath.2025.107515_bib126","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1128\/AAC.00558-10","article-title":"Structure of the Mycobacterium tuberculosis d -alanine: d -alanine ligase, a target of the antituberculosis drug d -cycloserine","volume":"55","author":"Bruning","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"issue":"9","key":"10.1016\/j.micpath.2025.107515_bib127","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1080\/07391102.2019.1637280","article-title":"Repurposing of FDA-approved drugs to target MurB and MurE enzymes in Mycobacterium tuberculosis","volume":"38","author":"Rani","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"7","key":"10.1016\/j.micpath.2025.107515_bib128","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1016\/j.bmc.2010.02.026","article-title":"Inhibition of Escherichia coli glycosyltransferase MurG and Mycobacterium tuberculosis Gal transferase by uridine-linked transition state mimics","volume":"18","author":"Trunkfield","year":"2010","journal-title":"Bioorg. Med. Chem."},{"issue":"4","key":"10.1016\/j.micpath.2025.107515_bib129","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1124\/mol.119.118042","article-title":"Structures of Mycobacterium tuberculosis penicillin-binding protein 3 in complex with five \u03b2 -lactam antibiotics reveal mechanism of inactivation","volume":"97","author":"Lu","year":"2020","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.micpath.2025.107515_bib130","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1046\/j.1365-2958.2003.03425.x","article-title":"Genes required for mycobacterial growth defined by high density mutagenesis: genes required for mycobacterial growth","volume":"48","author":"Sassetti","year":"2003","journal-title":"Mol. Microbiol."},{"issue":"8","key":"10.1016\/j.micpath.2025.107515_bib131","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1128\/JB.01857-07","article-title":"Nitrate enhances the survival of Mycobacterium tuberculosis during inhibition of respiration","volume":"190","author":"Sohaskey","year":"2008","journal-title":"J. Bacteriol."},{"issue":"12","key":"10.1016\/j.micpath.2025.107515_bib132","doi-asserted-by":"crossref","first-page":"4548","DOI":"10.1073\/pnas.0500469102","article-title":"Inhibitors of type II NADH:menaquinone oxidoreductase represent a class of antitubercular drugs","volume":"102","author":"Weinstein","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6685","key":"10.1016\/j.micpath.2025.107515_bib133","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/31159","article-title":"Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence","volume":"393","author":"Cole","year":"1998","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.micpath.2025.107515_bib134","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12393","article-title":"Turning the respiratory flexibility of Mycobacterium tuberculosis against itself","volume":"7","author":"Lamprecht","year":"2016","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.micpath.2025.107515_bib135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013356","article-title":"Nitrate respiration protects hypoxic Mycobacterium tuberculosis against acid- and reactive nitrogen species stresses","volume":"5","author":"Tan","year":"2010","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.micpath.2025.107515_bib136","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.1128\/AAC.00395-15","article-title":"Mode of action of clofazimine and combination therapy with benzothiazinones against Mycobacterium tuberculosis","volume":"59","author":"Lechartier","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"issue":"13","key":"10.1016\/j.micpath.2025.107515_bib137","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.1002\/ange.201800260","article-title":"Small molecules targeting Mycobacterium tuberculosis type II NADH dehydrogenase exhibit antimycobacterial activity","volume":"130","author":"Harbut","year":"2018","journal-title":"Angew. Chem."},{"issue":"1","key":"10.1016\/j.micpath.2025.107515_bib138","doi-asserted-by":"crossref","first-page":"20222","DOI":"10.1128\/mBio.02022-16","article-title":"A novel small-molecule inhibitor of the Mycobacterium tuberculosis demethylmenaquinone methyltransferase MenG is bactericidal to both growing and nutritionally deprived persister cells","volume":"8","author":"Sukheja","year":"2017","journal-title":"mBio"},{"issue":"12","key":"10.1016\/j.micpath.2025.107515_bib139","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1021\/acsinfecdis.7b00112","article-title":"Improved phenoxyalkylbenzimidazoles with activity against Mycobacterium tuberculosis appear to target QcrB","volume":"3","author":"Chandrasekera","year":"2017","journal-title":"ACS Infect. Dis."},{"issue":"1","key":"10.1016\/j.micpath.2025.107515_bib140","doi-asserted-by":"crossref","first-page":"7659","DOI":"10.1038\/ncomms8659","article-title":"Lansoprazole is an antituberculous prodrug targeting cytochrome bc1","volume":"6","author":"Rybniker","year":"2015","journal-title":"Nat. Commun."},{"issue":"32","key":"10.1016\/j.micpath.2025.107515_bib141","doi-asserted-by":"crossref","first-page":"13295","DOI":"10.1002\/anie.202002546","article-title":"Discovery of a novel mycobacterial F\u2010ATP synthase inhibitor and its potency in combination with diarylquinolines","volume":"59","author":"Hotra","year":"2020","journal-title":"Angew Chem Int Ed."},{"key":"10.1016\/j.micpath.2025.107515_bib142","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.3389\/fmicb.2018.02960","article-title":"Novel acetamide indirectly targets mycobacterial transporter MmpL3 by proton motive force disruption","volume":"9","author":"Shetty","year":"2018","journal-title":"Front. Microbiol."},{"issue":"1","key":"10.1016\/j.micpath.2025.107515_bib143","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/ncomms1060","article-title":"A chemical genetic screen in Mycobacterium tuberculosis identifies carbon-source-dependent growth inhibitors devoid of in vivo efficacy","volume":"1","author":"Pethe","year":"2010","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.micpath.2025.107515_bib144","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1021\/cb2004884","article-title":"A high-throughput screen to identify inhibitors of ATP homeostasis in non-replicating Mycobacterium tuberculosis","volume":"7","author":"Mak","year":"2012","journal-title":"ACS Chem. Biol."},{"issue":"1","key":"10.1016\/j.micpath.2025.107515_bib145","doi-asserted-by":"crossref","first-page":"6267","DOI":"10.1038\/ncomms7267","article-title":"Gene silencing by CRISPR interference in mycobacteria","volume":"6","author":"Choudhary","year":"2015","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.micpath.2025.107515_bib146","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/jac\/dkab437","article-title":"Utilization of CRISPR interference to investigate the contribution of genes to pathogenesis in a macrophage model of Mycobacterium tuberculosis infection","volume":"77","author":"Cheung","year":"2022","journal-title":"J. Antimicrob. Chemother."},{"issue":"18","key":"10.1016\/j.micpath.2025.107515_bib147","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1093\/nar\/gkw625","article-title":"Investigating essential gene function in Mycobacterium tuberculosis using an efficient CRISPR interference system","volume":"44","author":"Singh","year":"2016","journal-title":"Nucleic Acids Res."},{"issue":"6","key":"10.1016\/j.micpath.2025.107515_bib148","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/s41564-022-01130-y","article-title":"CRISPRi chemical genetics and comparative genomics identify genes mediating drug potency in Mycobacterium tuberculosis","volume":"7","author":"Li","year":"2022","journal-title":"Nat. Microbiol"},{"key":"10.1016\/j.micpath.2025.107515_bib149","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2015.00812","article-title":"The application of tetracyclineregulated gene expression systems in the validation of novel drug targets in Mycobacterium tuberculosis","volume":"6","author":"Evans","year":"2015","journal-title":"Front. Microbiol."},{"issue":"2","key":"10.1016\/j.micpath.2025.107515_bib150","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1093\/nar\/gni013","article-title":"Controlling gene expression in mycobacteria with anhydrotetracycline and Tet repressor","volume":"33","author":"Ehrt","year":"2005","journal-title":"Nucleic Acids Res."},{"issue":"8","key":"10.1016\/j.micpath.2025.107515_bib151","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134562","article-title":"An IPTG inducible conditional expression system for mycobacteria","volume":"10","author":"Ravishankar","year":"2015","journal-title":"PLoS One"}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401025002402?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401025002402?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T03:05:05Z","timestamp":1762311905000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401025002402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":151,"alternative-id":["S0882401025002402"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2025.107515","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advances in inhibitor development and metabolic targeting in tuberculosis therapy","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2025.107515","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107515"}}